Specialty pharma company focused on customized-formulation therapies
Azurity Pharmaceuticals is a Woburn-based specialty pharma company whose commercial engine runs on a deep Salesforce and Veeva CRM stack, paired with IQVIA data, Snowflake and Oracle Fusion for finance. Hiring is accelerating and overwhelmingly sales-led, with a manager-heavy mix. Projects like a next-best action engine, incentive compensation and field force alignment, plus Anthropic, OpenAI and RAG in the stack, point to AI-driven field sales optimization.
Notable leadership hires: Medical Director, Salesforce Lead, Head of Medical, Program Director, Head of Marketing
Azurity Pharmaceuticals is a privately held pharmaceutical company headquartered in Woburn, Massachusetts, with 501–1,000 employees. It develops therapies for patients who need customized formulations, with a portfolio spanning more than 50 medicines across 10 therapeutic areas. Its products reach patients in more than 50 countries. The company hires in the United States and India, across sales, healthcare, marketing, engineering, medical, operations, legal and finance functions.
Azurity uses Salesforce (Sales, Service, Marketing and Experience Cloud), Veeva CRM, IQVIA, Snowflake, SAP, Oracle Fusion Financials, Concur, Python, React, AWS, Azure, GCP, plus OpenAI and Anthropic.
Yes. Hiring is accelerating and heavily sales-led, mostly at manager and senior levels, alongside healthcare, marketing, medical and engineering roles in the United States and India.
Azurity Pharmaceuticals is headquartered in Woburn, Massachusetts, United States, and is a privately held company with 501–1,000 employees.
Other companies in the same industry, closest in size
Azurity Pharmaceuticals's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.